Search results
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 24 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 3 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? | The Motley...
The Motley Fool· 6 days agoWall Street is feeling pretty good about AbbVie's (ABBV -1.19%) performance in 2024 so far. Chen...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 4 days agoNext earnings report is scheduled for 64 days from now. What Analysts Are Saying About AbbVie Over the past month, 3 industry analysts have shared their insights on this & ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare ...
AbbVie Completes Acquisition of Landos Biopharma
Quincy Herald-Whig· 3 days agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...
Selling Buzz: Abbvie Inc [ABBV] EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas sells 21,082 shares...
Knox Daily· 3 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $3,716,757 were sold by ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 2 days agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Monitoring Abbvie Inc (ABBV) after recent insider movements – Knox Daily
Knox Daily· 6 days agoJ. now holds 13,837 shares, worth roughly $2.3 million. Cantor Fitzgerald initiated its Abbvie Inc [ABBV] rating to an Overweight in a research note published on May 17, 2024 ...
A Must-Own Stock for Any Portfolio
Motley Fool via Yahoo Finance· 4 days ago*Stock prices used were end-of-day prices of May 17, 2024. The video was published on May 20, 2024. Should you invest $1,000 in AbbVie right now? Before...